Endocrinology News

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.

In patients with severe hypertriglyceridemia, plozasiran, a novel RNA interference agent, lowered apolipoprotein C-III and triglycerides and improved other lipid parameters, according to the final results of the phase 2b SHASTA-2 trial.

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

BOSTON — In a phase 2b trial, a hormonal contraceptive gel for use by men worked faster than expected, suppressing sperm count to effective levels by week 8 of use, making it an “attractive” product, according to a speaker at ENDO 2024.

BOSTON — The percentage of women with osteoporosis who also had diabetes increased from 2009-2010 to 2017-2018, despite a decline in overall diabetes rates for women aged 50 years and older, according to data presented at ENDO 2024.

BOSTON — Vitamin D test results have become more reliable during the past decade after quality improvement measures, but inaccuracies persist for some assays that can affect diagnosis and treatment decisions, researchers reported.

In this Healio video exclusive, a speaker at the National Lipid Association Scientific Sessions discusses opportunities for heart disease prevention in women at the time of menopause transition.

Results of Women’s Health Initiative trials highlight the importance of personalized health care in combination with shared decision-making for postmenopausal women, according to a review published in JAMA.

BOSTON — Most nonbinary people who initiated low-dose transdermal testosterone for gender affirmation continued taking doses that were lower than current guideline recommendations at 1 year, researchers reported at ENDO 2024.

One of the most important questions physicians will need to answer is whether they will hire a financial advisor to help them manage their wealth or do it themselves.